Agios Pharmaceuticals Inc (NASDAQ:AGIO)

37.74
Delayed Data
As of Sep 13
 -0.41 / -1.07%
Today’s Change
33.17
Today|||52-Week Range
79.17
-18.15%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close38.15
Today’s open38.27
Day’s range36.67 - 38.48
Volume927,387
Average volume (3 months)567,695
Market cap$2.2B
Data as of 3:59pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+10.72%
Earnings growth (this year)-15.91%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+119.45%
P/E ratioNM
Price/Sales28.05
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.22+0.72%
RETAReata Pharmaceutical...+1.43+1.68%
ICPTIntercept Pharmaceut...+0.83+1.22%
BHVNBiohaven Pharmaceuti...+2.05+4.56%
Data as of 6:30pm ET, 09/13/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)-$1.75
Annual revenue (last year)$94.4M
Annual profit (last year)-$346.0M
Net profit margin-366.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jacqualyn A. Fouse
CFO &
Head-Corporate Development
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts